1. Pham S, Heigle B, Gibbs C, Gebrehiwot WG, Pannu P. Complications of infective endocarditis: A case report of intracerebral hemorrhage exacerbated by enoxaparin. Cureus. 2024;16(5):e61235. [
DOI:10.7759/cureus.61235]
2. Kesieme EB, Omoregbee B, Ngaage DL. A case report supporting early surgery in mitral valve infective endocarditis with recurrent cerebral infarcts. Eur Heart J Case Rep. 2024;8(12): ytae64. [
DOI:10.1093/ehjcr/ytae641]
3. Amouzeshi A, Zargaz SE, Rezaei M, Riahi SM, Sa'adat F. The comparison of postoperative complications in hypothyroid and euthyroid patients undergoing cardiac surgery: A retrospective cohort study. Int Cardiovascu Res J. 2023;17(1):24-30.
4. Nappi F, Spadaccio C, Dreyfus J, Attias D, Acar C, Bando K. Mitral endocarditis: A new management framework. J Thorac Cardiovasc Surg. 2018;156(4):1486-95. [
DOI:10.1016/j.jtcvs.2018.03.159]
5. Cartwright B, Mundell N. Anticoagulation for cardiopulmonary bypass: part one. BJA Educ. 2023;23(3):110-6. [
DOI:10.1016/j.bjae.2022.12.003]
6. McKinley WI, Rowell SE, Mansour A, Hoefer L, Polcari A, Schreiber M, et al. Tranexamic acid, mortality, and intracranial hemorrhage type in moderate or severe traumatic brain injury. JAMA Surg. 2023;158(11):1222-4. [
DOI:10.1001/jamasurg.2023.3848]
7. Hu W, Xin Y, Chen X, Song Z, He Z, Zhao Y. Tranexamic acid in cerebral hemorrhage: a meta-analysis and systematic review. CNS Drugs. 2019; 33:327-36. [
DOI:10.1007/s40263-019-00608-4]
8. Xiong Y, Guo X, Huang X, Kang X, Zhou J, Chen C, et al. Efficacy and safety of tranexamic acid in intracranial haemorrhage: A meta-analysis. PLoS One. 2023;18(3):e0282726. [
DOI:10.1371/journal.pone.0282726]